Endoscopic follow-up of positive fecal occult blood testing in the Ontario FOBT Project

Canadian Journal of Gastroenterology

Volumn 21, Issue 6, 2007, Pages 379-382

  Paszat, Lawrence ^a   Rabeneck, Linda ^a,b   Kiefer, Lori ^a,b   Mai, Verna ^a,c   Ritvo, Paul ^b,d   Sullivan, Terry ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CANCER CARE ONTARIO   (Canada)

^c Cancer Care Ontario ^*  (Canada)

^d YORK UNIVERSITY   (Canada)

Author keywords

Colonoscopy; Colorectal cancer; Fecal occult blood testing (FOBT); Screening

Indexed keywords

ADULT; AGED; ARTICLE; BARIUM ENEMA; CANADA; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; ENDOSCOPY; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEALTH INSURANCE; HUMAN; LABORATORY TEST; MALE; MEDICAL RECORD; OCCULT BLOOD; PILOT STUDY; POLYPECTOMY; PRIORITY JOURNAL; PUBLIC HEALTH; VOLUNTEER;

EID: 34547425843     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/569689     Document Type: Article

References (14)

1. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 1998;317:559-65.
2. Canadian Task Force on Preventive Health Care. Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2001;165:206-8.
3. Ederer F, Church TR, Mandel JS. Fecal occult blood screening in the Minnesota study: Role of chance detection of lesions. J Natl Cancer Inst 1997;89:1423-8.
4. World Health Organization (WHO). National Cancer Control Programmes: Policies and Managerial Guidelines, 2nd edn. Geneva, World Health Organization, 2002.
5. Vinden C, Schultz S, Rabeneck L. ICES research atlas: Use of large bowel procedures in Ontario. (Version current at January 5, 2007).
6. Rabeneck L, Paszat LF. A population-based estimate of the extent of colorectal cancer screening in Ontario. Am J Gastroenterol 2004;99:1141-4.
7. Saunders BP, Fukumoto M, Halligan S, et al. Why is colonoscopy more difficult in women? Gastrointest Endosc 1996;43:124-6.
8. Stockwell DH, Woo P, Jacobson BC, et al. Determinants of colorectal cancer screening in women undergoing mammography. Am J Gastroenterol 2003;98:1875-80.
9. Thiis-Evensen E, Hoff GS, Sauar J, Vatn MH. Patient tolerance of colonoscopy without sedation during screening examination for colorectal polyps. Gastrointest Endosc 2000;52:606-10.
10. Grazzini G, Castiglione G, Ciabattoni C, et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: First round results. Eur J Cancer Prev 2004;13:19-26.
11. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 2006;15:389-94.
12. Church TR, Yeazel MW, Jones RM, et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst 2004;96:770-80.
13. National Health Service. Evaluation of the UK colorectal cancer screening pilot. (Version current at January 5, 2007).
14. Price J, Campbell C, Sells J, et al. Impact of UK Colorectal Cancer Screening Pilot on hospital diagnostic services. J Public Health (Oxf) 2005;27:246-53.